|
Pharmaceutical Products – Conclusion Of A Non-Exclusive Discount Agreement According To Section 130A Paragraph 8 Or 130C Paragraph 1 Sgb V For The Period From October 1St, 2026 To Usually September 30Th, 2028. Active Ingredient Anagrelide; Atc Code L01xx35; Dosage Form Hkp; Potency 0.5 Mg; Pack Size 42 Pieces (Without Clinic Packs),Active Ingredient Atorvastatin And Ezetimibe; Atc Code C10ba05; Dosage Form Fta, Tab, Hkp; Potency 10.82/10 Mg/Mg; 21.65/10 Mg/Mg; 43.3/10 Mg/Mg; 86.6/10 Mg/Mg; Pack Size 88 Pieces (Excluding Clinic Packs);,Active Ingredient Bimatoprost; Atc Code S01ee03; Dosage Form Atr; Potency 0.1 Mg, 0.3 Mg; Pack Size N1 (Excluding Clinical Packs);,Active Ingredient Buprenorphine; Atc Code N02ae01; Dosage Form Pft 0.035 Mg/H 5, 8; Pft 0.0525 Mg/H 4, 5, 8; Pft 0.07 Mg/H 4, 5, 8; Potency See Dosage Form; Pack Size See Dosage Form (Excluding Clinical Packs);,Active Ingredient Calcipotriol, Combinations; Atc Code D05ax52; Dosage Form Cre; Potency 0.05/0.5 Mg/Mg; Pack Size N2, N3 (Excluding Clinical Packs);,Active Ingredient Cilcopirox; Atc Code D01ae14; Dosage Form Cre 7.72 Mg N1, N2, N3; Loe 7.72 Mg N1, N2; Potency See Dosage Form; Pack Size See Dosage Form (Excluding Clinical Packs);,Active Ingredient Colecalciferol; Atc Code A11cc05; Dosage Form Hkp 25,000 Iu 40; Iim 100,000 Iu N1; Lse 25,000 Iu 1, 2, 4; Tab 400 Iu N3; Tei 2,400 Iu N1, 30; Tei 10,000 Iu N1; Wka 1,000 N2, N3; Wka 3,200 30; Wka 20,000 4, 6, 10, 30; Wka 25,000 6, N2; Potency See Dosage Form; Pack Size See Dosage Form (Excluding Clinical Packs);,Active Ingredient Dutasteride; Atc Code G04cb02; Dosage Form Wka; Potency 0.5 Mg; Pack Size N2 (Excluding Clinical Packs);,Active Ingredient Escitalopram; Atc Code N06ab10; Dosage Form Fta Smt; Potency 5, 10, 15, 20 Mg; Pack Size 28 Pieces (Without Clinic Packs);,Active Ingredient Famotidine; Atc Code A02ba03; Dosage Form Fta, Tab; Potency 20 Mg, 40 Mg; Pack Size N2 (Excluding Clinical Packs);,Active Ingredient Hydrocortisone; Atc Code D07aa02; Dosage Form Cre 2.24 Mg N3 Emu 10 Mg N2, N3; Loe 10 Mg N2, N3; Potency See Dosage Form; Pack Size See Dosage Form (Excluding Clinical Packs);,Active Ingredient Ibuprofen; Atc Code M01ae01; Dosage Form Fta Kap Kta Smt Tab Uta Wka 400 Mg, 600 Mg, 800 Mg 10; Gra 600 Mg N1, N2; Inf 200 Mg N2; Inf 400 Mg N2, 20; Inf 600 Mg N2, 20; Potency See Dosage Form; Pack Size See Dosage Form (Excluding Clinical Packs);,Active Ingredient Levodopa, Decarboxylase Inhibitors And Comt Inhibitors; Atc Code N04ba03; Dosage Form Gel; Potency 940/217.67/940; Pack Size N2 (Excluding Clinical Packs);,Active Ingredient Meloxicam; Atc Code M01ac06; Dosage Form Tab 7.5 Mg N1, N2, N3; Tab 15 Mg 10, N1, N2, N3; Potency See Dosage Form; Pack Size See Dosage Form (Excluding Clinical Packs);,Active Ingredient Mometasone; Atc Code R01ad09; Dosage Form Nas Nds; Potency 0.05 Mg; Pack Size 280 Pieces (Excluding Clinic Packs);,Active Ingredient Perindopril And Diuretics; Atc Code C09ba04; Dosage FormFta 1.704/0.625 N1, N3; Fta 3.408/1.25 N1, N3; Fta Tab 1.697/0.625 N1, N3, 90; Fta Tab 3.395/1.25 N1; Tab 1.669/0.625 N1, N3; Tab 3.338/1.25 N1, N2; Tab 6.675/2.5 N1; Potency See Dosage Form; Pack Size See Dosage Form (Excluding Clinical Packs);,Active Ingredient Quetiapine; Atc Code N05ah04; Dosage Form Fta 150 Mg 20; Fta 400 Mg N1, 20; Potency See Dosage Form; Pack Size See Dosage Form (Excluding Clinical Packs);,Active Ingredient Riluzole; Atc Code N07xx02; Dosage Form Fta 50 Mg N2; Smf 50 Mg N1, N2, N3; Sae 50 Mg N2; Potency See Dosage Form; Pack Size See Dosage Form (Excluding Clinical Packs);,Active Ingredient Tadalafil; Atc
|
